Bayer concerned about EU decision neonicotinoids
Bayer CropScience considers the decision by the Commission of the European Union to restrict the use of neonicotinoid-containing products across Europe as a set-back for technology, innovation and sustainability. In an Appeals Committee meeting today, only half of the EU Member States supported the Commission’s proposal for the restrictions. The company believes that the plan by the Commission will not have a positive impact on bee health.
The company is concerned that the restriction of these neonicotinoids will result in crop yield losses, reduced food quality and loss of competitiveness for European agriculture. This will have a negative impact on farmers, R&D driven ag companies, the seed industry and the food value chain.
As a science-based company, Bayer CropScience is disappointed that clear scientific evidence has taken a back-seat in the decision making process. This disproportionate decision is a missed opportunity to reach a solution that takes into consideration all of the existing product stewardship measures and broad stakeholder concerns. The further reduction of effective crop protection products will put at risk farmers’ ability to tackle important pests that can severely restrict their ability to grow high-quality food.
Bayer CropScience remains convinced that neonicotinoids are safe for bees, when used responsibly and properly, according to label instructions. The company will work together with all relevant stakeholders and authorities in the Member States to handle the complex consequences of this decision, to further support its customers.
Source: HortiBiz - 2 May 2013